New York- and Chicago-based Meadowbrook Capital Management has launched its second hedge fund, a long/short all-cap offering, to complement its existing small- and micro-cap fund.
The Meadowbrook Beta Neutral Fund, managed by Afsin Alp, launched on July 1 with $10 million, investing in healthcare technology sector. The fund charges a 2% management fee and a 20% performance fee.
Meadowbrook’s existing Meadowbrook Opportunity Fund currently manages some $35 million in assets.
Gabriel KurlandBy Gabriel Kurland: On November 12, 2009, the U.K.’s Serious Fraud Office (“SFO”), an independent government department that investigates and prosecutes fraud and corruption cases, announced that it is probing the London-based, Dynamic Decisions Capital Management Ltd., after the matter was referred to it by the Financial Services Authority. More...
Ireland has launched the EUR 26 million ($40 million) Bank of Ireland Seed and Early Stage Equity Fund to invest in startup and early stage companies. More...